Study identifies effective ketamine doses for treatment-resistant depression

(Massachusetts General Hospital) A study led by Massachusetts General Hospital investigators identifies two subanesthetic dosage levels of the anesthetic drug ketamine that appear to provide significant symptom relief to patients with treatment-resistant depression.
Source: EurekAlert! - Social and Behavioral Science - Category: International Medicine & Public Health Source Type: news